statistics
 
Home   Contact Us   Sitemap



 Overview  Milestones  Accolades  Board of Directors  History  Social Responsibility
 
 
Overview :

Indoco Remedies is engaged in the manufacturing and marketing of Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs) in India. Indoco has a strong international presence in the Regulated and Emerging markets. The Company is striving to place itself on a strong promising path by expanding its business strategically, strengthening its manufacturing facilities and enhancing capabilities across the organization. The Company is looking at various opportunities in untapped markets and association with business partners in the global markets to boost its revenues.

As a company, Indoco remains focused on APIs & Formulations business and will be looking to expand the same, both in the domestic as well as international markets. Indoco today, has a well-built brand portfolio of 135 products in various therapeutic segments, including high growth life style segments such as Anti-Diabetics, Cardiovascular, Central Nervous System, Musculo-Skeletal, Nutrition and Dental care.

 
Global Footprint :

Indoco has built a visible presence across all it's markets in Europe, USA, Asia, Africa, Latin America and other CIS countries. A number of its products have emerged as brand leaders in the Indian and in International markets. Indoco has made significant investments to build capabilities in API manufacturing and R & D services to enhance its visibility. As of today, the company operates in over 35 countries globally for Formulations and APIs. With approval of its Finished Dosage facilities by the US - FDA, Darmstadt Germany, TGA Australia, MCC-South Africa and UK - MHRA, Indoco has emerged as the most suitable partner and provider of Contract Research and Manufacturing Services (CRAMS) to its customers globally. With a sizeable basket of own Dossiers in CTD format, Indoco is all set to offer the full range of services including APIs with DMFs/CoS and CTD Dossiers with supply of Finished Dosages.